Vulvodynia and persistent vulvar pain –⁠ diagnosis, treatment, and the role of laser vaporization

Czech version

Authors: R. Chmel jr.; N. Chubanovová; Z. Pastor
Authors‘ workplace: Gynekologicko-porodnická klinika 2. LF UK a FN Motol a Homolka, Praha
Published in: Ceska Gynekol 2026; 91(2): 124-130
Category:
doi: https://doi.org/10.48095/cccg2026124

Overview

This article reviews the issue of persistent vulvar pain and vulvodynia, which are common conditions in women of reproductive age. Vulvodynia is defined as chronic vulvar pain lasting at least 3 months with no identified cause. It is characterized by increased sensitivity of the vulvar and vestibular tissues, neuroproliferation, increased vascularization, and structural changes of the mucosa. In contrast, persistent vulvar pain is usually associated with a specific, identifiable underlying condition. Both types of pain may coexist and overlap. This article comments on the current classification of vulvar pain according to the consensus of international societies dealing with this condition. It also summarizes the principles of differential diagnosis and therapeutic options for the management of vulvar pain. Treatment should be based on a comprehensive multidisciplinary approach including local and systemic pharmacotherapy, physiotherapy, psychotherapy, and in selected cases, surgical interventions. This article focuses on novel and promising therapeutic modalities in the treatment of vulvodynia, particularly various types of laser therapy. The review is supplemented by a case report of a patient with chronic provoked vestibulodynia treated by laser vaporization.

Keywords:

chronic pain – laser therapy – vulvodynia – persistent vulvar pain – vestibulodynia

Sources

1. Xie Y, Shi L, Xiong X et al. Economic burden and quality of life of vulvodynia in the United States. Curr Med Res Opin 2012; 28 (4): 601–608. doi: 10.1185/03007995.2012.666963.

2. Kestřánek J, Matula V, Pidrman V et al. Nový pohled na problematiku vulvodynie. Ceska Gynekol 2010; 75 (6): 521–526.

3. Harlow BL, Kunitz CG, Nguyen RH et al. Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographical regions. Am J Obstet Gynecol 2014; 210 (1): 40.e1–40.e8. doi: 10.1016/j.ajog.2013.09.033.

4. Pukall CF. Primary and secondary provoked vestibulodynia: a review of overlapping and distinct factors. Sex Med Rev 2016; 4 (1): 36–44. doi: 10.1016/j.sxmr.2015.10.012.

5. Bornstein J, Goldstein AT, Stockdale CK et al. 2015 ISSVD, ISSWSH and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. Obstet Gynecol 2016; 127 (4): 745–751. doi: 10.1097/AOG.00000 00000001359.

6. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc (1972) 2003; 58 (2): 82–88.

7. Chalmers KJ, Madden VJ, Hutchinson MR et al. Local and systemic inflammation in localized, provoked vestibulodynia: a systematic review. Obstet Gynecol 2016; 128 (2): 337–347. doi: 10.1097/AOG.0000000000001510.

8. Moyal-Barracco M, Lynch PJ. 2003 terminology and classification of vulvodynia: a historical perspective. J Reprod Med 2004; 49 (10): 772–777.

9. Harlow BL, Vazquez G, MacLehose RF et al. Self-reported vulvar pain characteristics and their association with clinically confirmed vestibulodynia. J Womens Health 2009; 18 (9): 1333–1340. doi: 10.1089/jwh.2008.1032.

10. Corsini-Munt S, Rancourt KM, Dubé JP et al. Vulvodynia: a consideration of clinical and methodological research challenges and recommended solutions. J Pain Res 2017; 10 : 2425–2436. doi: 10.2147/JPR.S126259.

11. Schlaeger JM, Glayzer JE, Villegas-Downs M et al. Evaluation and treatment of vulvodynia: state of the science. J Midwifery Womens Health 2023; 68 (1): 9–34. doi: 10.1111/jmwh.13456.

12. Lev-Sagie A, Witkin SS. Recent advances in understanding provoked vestibulodynia. F1000Res 2016; 5 : 2581. doi: 10.12688/f1000 research.9603.1.

13. Goldstein SW, Goldstein I, Kim NN et al. Safety and efficacy of fractional CO₂ laser treatment to the vestibule: a randomized, double-blind, sham-controlled prospective 3-site clinical study in women with vestibular pain. J Sex Med 2023; 20 (6): 800–812. doi: 10.1093/jsxmed/qdac053.

14. Jackman VA, Bajzak K, Rains A et al. Physical modalities for the treatment of localized provoked vulvodynia: a scoping review of the literature from 2010 to 2023. Int J Womens Health 2024; 16 : 769–781. doi: 10.2147/IJWH.S445167.

15. Lev-Sagie A, Kopitman A, Brzezinski A. Low--level laser therapy for the treatment of provoked vestibulodynia: a randomized, placebo--controlled pilot trial. J Sex Med 2017; 14 (11): 1403–1411. doi: 10.1016/j.jsxm.2017.09.004.

16. Morin M, Paré J, Dumont V et al. A randomized prospective pilot study investigating the feasibility and effects of high intensity laser therapy for women with vulvodynia. J Sex Med 2022; 19 (Suppl 3): S1. doi: 10.1016/j.jsxm.2022.05.008.

17. Murina F, Karram M, Salvatore S et al. Fractional CO₂ laser treatment of the vestibule for patients with vestibulodynia and genitourinary syndrome of menopause: a pilot study. J Sex Med 2016; 13 (12): 1915–1917. doi: 10.1016/j.jsxm.2016.10.006.

18. Santangelo G, Ruggiero G, Murina F et al. Vulvodynia: a practical guide in treatment strategies. Int J Gynaecol Obstet 2023; 163 (2): 510–520. doi: 10.1002/ijgo.14815.

19. Starzec-Proserpio M, Grigol Bardin M, Morin M. Not all lasers are the same: a scoping review evaluating laser therapy for vulvodynia. Sex Med Rev 2024; 12 (1): 14–25. doi: 10.1093/sxmrev/qead039.

20. Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med 1987; 32 (2): 110–114.

21. World Health Organization. International Classification of Diseases for Mortality and Morbidity Statistics, 11th revision. Geneva: WHO 2019.

22. Pastor Z, Jonášová M. Co přinesla nová klasifikace MKN-11 v kategorizaci ženských sexuálních dysfunkcí? Ceska Gynekol 2022; 87 (6): 432–439. doi: 10.48095/cccg2022432.

23. Bajzak K, Rains A, Bishop L et al. Pharmacological treatments for localized provoked vulvodynia: a scoping review. Int J Sex Health 2023; 35 (3): 427–443. doi: 10.1080/19317611.2023. 2222114.

24. Rosen NO, Bergeron S, Pukall CF. Recommendations for the study of vulvar pain in women, part 1: review of assessment tools. J Sex Med 2020; 17 (2): 180–194. doi: 10.1016/j.jsxm.2019.10.023.

25. Rosen NO, Bergeron S, Pukall CF. Recommendations for the study of vulvar pain in women, part 2: methodological challenges. J Sex Med 2020; 17 (4): 595–602. doi: 10.1016/j.jsxm.2019.12.018.

26. Hurt K, Švestková O, Halaška M et al. Extra--korporeální rázová vlna v léčbě vulvodynie: studie proveditelnosti. Actual Gyn 2019; 11 : 18–22.

27. Swanson CL, Rueter JA, Olson JE et al. Localized provoked vestibulodynia: outcomes after modified vestibulectomy. J Reprod Med 2014; 59 (3–4): 121–126.

28. David A, Borstein J. Evaluation of long-term surgical success and satisfaction after vestibulectomy. J Low Genit Tract Dis 2020; 24 (4): 399–404. doi: 10.1097/LGT.0000000000000552.

29. Goldstein AT, Klingman D, Christopher K et al. Surgical treatment of vulvar vestibulitis syndrome: outcome assessment derived from a postoperative questionnaire. J Sex Med 2006; 3 (5): 923–931. doi: 10.1111/j.17 43-6109.2006.00303.x.

30. Davis SN, Bergeron S, Binik YM et al. Women with provoked vestibulodynia experience clinically significant reductions in pain regardless of treatment. J Sex Med 2013; 10 (12): 3080–3087. doi: 10.1111/jsm.12309.

31. Basson R, Driscoll M, Correia S. When sex is always painful: provoked vestibulodynia. BCMJ 2016; 58 (2): 77–81.

32. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6 (2): 135–142. doi: 10.1038/ni1158.

33. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353 (9168): 1959–1964. doi: 10.1016/S0140-6736 (99) 01307-0.

34. Perelmuter S, Giovannetti O, Tomalty D. Review of the vestibular glands: functional anatomy, clinical significance, and role in sexual function. Sex Med Rev 2025; 13 (4): 687–697. doi: 10.1093/sxmrev/qeaf027.

35. Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest 2004; 58 (3): 171–178. doi: 10.1159/000079663.

36. Warner TF, Tomic S, Chang CK. Neuroendocrine cell–axonal complexes in the minor vestibular gland. J Reprod Med 1996; 41 (6): 397–402.

37. Saçıntı KG, Razeghian H, Bornstein J. Surgical treatment for provoked vulvodynia: a systematic review. J Low Genit Tract Dis 2024; 28 (4): 379–390. doi: 10.1097/LGT.0000000000 000834.

38. Bohm-Starke K, Wilbe Ramsay K, Lytsy P et al. Treatment of provoked vulvodynia: a systematic review. J Sex Med 2022; 19 (5): 789–808. doi: 10.1016/j.jsxm.2022.02.008.